COMMUNIQUÉS West-GlobeNewswire

Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
17/10/2024
Total eligible patients in the US exceed 2 million. Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active treatment. Reflects business philosophy of commercial success through patient [...]
TOMI Environmental Solutions, Inc. Announces Record Q3 2024 iHP Corporate Service Revenue
17/10/2024
FREDERICK, Md., Oct. 17, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination technologies, today announced that its iHP Corporate [...]
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
17/10/2024
AMSTERDAM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) – RenovaroCube, a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies, is excited to announce the presentation of its latest [...]
Nordic Naturals Completes 40th Annual California Coastal Cleanup with National Retail Support
17/10/2024
WATSONVILLE, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nordic Naturals , a worldwide leader in providing premium omega-3 fish oils and other essential nutrient supplements, successfully wrapped up its participation in [...]
Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton
17/10/2024
SOUTH ORANGE, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH) Nephros, Inc., a leader in advanced filtration technology, is proud to announce its rapid response to the recent hurricanes which [...]
Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment
17/10/2024
Access the CEO Connect segment here ISELIN, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the [...]
Solera Health Study Suggests Virtual Healthcare Networks Can Reduce the Cost of Care by up to 3.1%
17/10/2024
Potential Savings Equate to Over $50 Billion in U.S. Annual Private Insurer Expenditures PHOENIX, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Solera Health , a unique technology platform for connecting people seamlessly and [...]
Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur
16/10/2024
SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer [...]
Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe
16/10/2024
-Lexicon to receive an upfront payment of $25 million and the potential for contingent regulatory and commercial milestone payments THE WOODLANDS, Texas, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. ( [...]
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
16/10/2024
Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with management GERMANTOWN, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American [...]
Teladoc Health to Announce Third Quarter 2024 Financial Results
16/10/2024
PURCHASE, NY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2024 results on Wednesday, October 30, 2024 [...]
Tevogen Bio Thanks Warren Township for Proclamation Honoring CEO Dr. Ryan Saadi, Nobel Peace Prize Nomination, and the Company's Mission to Address Health Inequality
16/10/2024
WARREN, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T [...]
Capricor Therapeutics Announces Proposed Public Offering of Common Stock
16/10/2024
SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today [...]
Ezra, Full-Body MRI Leader, Launches AI-Powered Scans to Philadelphia in Partnership with Princeton Radiology
16/10/2024
Healthcare startup brings early cancer detection technology to Pennsylvania for the first time NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Ezra , the company revolutionizing early cancer detection through full-body MRI [...]
Certara Appoints John Reynders as New Independent Board Member
16/10/2024
RADNOR, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of John Reynders, PhD, to its Board of Directors, [...]
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer
16/10/2024
– Mr. Tamberrino and Profound’s CEO, Arun Menawat, previously worked together at NOVADAQ before it was acquired by Stryker in 2017 – – Appointment comes as Profound continues to make final preparations for the permanent [...]
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
16/10/2024
IRVINE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp . (NASDAQ: OCX), a diagnostics technology company, announced today that CEO Josh Riggs is scheduled to present at the 17th annual Main Event, hosted by LD [...]
Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024
16/10/2024
In vitro data on SPR719 show low propensity for resistance development in NTM-PD MAC strains when administered as a single agent and in combination with standard of care agents Study highlighting SPR720 potential [...]
NeuroPace Continues to Strengthen Management Team
16/10/2024
Appoints experienced people leader as Vice President of Human Resources MOUNTAIN VIEW, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives [...]

Pages